Cost-Effectiveness of Active Surveillance, Radical Prostatectomy and External Beam Radiotherapy for Localized Prostate Cancer: An Analysis of the ProtecT Trial
Vidit Sharma(University of California, Los Angeles), Stephen A. Boorjian(Mayo Clinic), Kevin Wymer(Mayo Clinic), R. Jeffrey Karnes(Mayo Clinic), R. Houston Thompson(Dalhousie University), Daniel A. Barocas(Vanderbilt University Medical Center), Bijan J. Borah(Mayo Clinic in Florida)
Cited by 36
Related Papers
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592
Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline
|The Journal of Urology|2012|487